Where to inject Mounjaro in the stomach: choosing the right spot

You're standing at the fridge with your first Mounjaro pen, here's where to go

Most people find it easiest to inject into the lower abdomen, roughly level with and to either side of the hip bones. Think of a band of tissue running from about two inches clear of the navel outward toward each hip. That zone has plenty of subcutaneous fat just under the skin, which is exactly where the tirzepatide needs to land. Injecting into muscle instead gives a sharper sting and unpredictable absorption, subcutaneous tissue, not muscle, is the target.

Before you press the pen against your skin, wipe the chosen spot with an alcohol swab and let it dry for a few seconds. Wet skin stings more and can introduce moisture into the injection site. Pinch a fold of skin between your thumb and forefinger (a light, comfortable pinch) hold the KwikPen flat against it at a right angle, and press the button. The pen deposits the dose and then you wait for the orange indicator before withdrawing it. That pause, usually around ten seconds, matters: pulling away too early can leave some of the dose on the surface of the skin rather than in the tissue.

The Mounjaro KwikPen is designed so you cannot see the needle, which most people find reassuring. If you are curious about how the pen mechanism operates, the guide on how the Mounjaro pen works walks through every stage. For a broader look at all licensed sites, the NHS medicines page for tirzepatide is worth bookmarking alongside your Patient Information Leaflet.

Why rotation across the stomach matters more than most people expect

Using the same square inch of abdomen week after week causes lipohypertrophy, a thickening and hardening of the subcutaneous tissue that forms when fat cells are repeatedly traumatised. Injecting into lipohypertrophied skin feels different (often less painful, which is why people keep returning to the same spot), but absorption becomes erratic. Studies in insulin-dependent patients show that lipohypertrophy is one of the leading causes of unexplained dose variability, and the same principle applies to GLP-1 injections.

A simple rotation plan: divide your lower abdomen into four imaginary quadrants, lower left, lower right, upper left of the cleared zone, upper right. Use one quadrant per week in sequence, then cycle back. Within each quadrant, vary the exact spot by at least an inch from the previous injection in that zone. This gives any single site roughly a month to recover between doses.

If you notice any hard lumps, persistent redness or unusual swelling at a previous injection site, mention it at your next clinical review. Changing technique early prevents the issue from becoming entrenched. More detail on the full stomach site map (including how to judge boundaries and what to look for when assessing your own skin) is covered in the Mounjaro stomach injection sites guide.

What to avoid when choosing where on the stomach to inject Mounjaro

Several areas within the abdominal region are best left alone. The navel itself and roughly two inches around it are a no-go: the skin is thinner, the tissue structure different, and absorption less predictable. Stretch marks are not automatically excluded, but injecting repeatedly into the same stretch-marked line can cause localised discomfort, vary away from them where possible. Scars from previous surgery, active skin infections, rashes, bruising and any area that is tender or swollen should all be avoided until the skin has fully recovered.

People sometimes ask whether they should inject Mounjaro on an empty stomach, given that tirzepatide slows gastric emptying. The short answer is that meal timing around the injection does not affect how the drug absorbs subcutaneously. If that question is on your mind, the page on whether to inject Mounjaro on an empty stomach addresses it properly. What does affect absorption is the depth and location of the injection, landing in subcutaneous tissue rather than muscle or skin surface is the consistent factor.

If you are switching between sites (say, moving from the stomach to the thigh one week) this is fine and often encouraged. The thigh and upper arm are equally licensed. The full injection-site overview for Mounjaro covers the thigh and arm options for weeks when the abdomen is off-limits due to a bruise or sensitivity. Disposal of used pens in an approved sharps container is a legal requirement, never in general household waste.

How this fits into your ongoing treatment and clinical support

Getting injection technique right is part of treatment, not a footnote. Poor technique (shallow injections that miss subcutaneous tissue, or returning obsessively to a favourite spot) can blunt a dose's effect just as much as forgetting to take it. Most of the adjustments people need come early, in the first few weeks, and settle quickly once the habit is established.

Mounjaro is a prescription-only medicine. A GPhC-registered prescriber, not a software system, reviews every consultation and every repeat order at nume. If technique questions come up between orders, the aftercare team is available seven days a week. Broader context about who this treatment is appropriate for and how the clinical pathway works sits on the Mounjaro treatment page, and anyone ready to start can speak to our prescribers through a free, same-day-reviewed consultation. For those still weighing up the options alongside other approaches, the weight-loss treatments overview is a useful starting point.